Collaborative partnerships can foster success in formulation development projects.

Developing the Best Formulation Partnership

The CRO market will see consolidation by financial buyers and larger CRO players.

Pharma Services Sector Poised for Continued Growth

Topic

Editor of Pharmaceutical Technology Europe

Articles

Particle analysis is a critical component of pharmaceutical development, providing assurances of the quality and performance of the final dosage form.

Not a Particle of Doubt

Sartorius is investing €100 million (US$113 million) between 2021 and 2025 to expand capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy, and Lourdes.

Sartorius to Invest in Growing Operations in France

Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.

Sartorius Launches Expansion in South Korea with Mullti-Million Dollar Investment

Luc Gagnon, PhD, is vice-president of Vaccine Sciences at Nexelis.

Partnerships formed during the COVID-19 pandemic have provided a platform for change in assay development and transfers that should continue in the future.

The Key Elements for Assay Transfer Success

CordenPharma will build a clinical trial development facility for manufacture of oral solid dosage drug products at its Plankstadt facility near Heidelberg, Germany.

CordenPharma Adds Highly Potent Capabilities in Germany

Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp. have partnered to advance GreenLight’s mRNA COVID-19 vaccine candidate.

Samsung Biologics, GreenLight Biosciences, and Environmental Impact Acquisition Corp to Build mRNA Vaccine Manufacturing Capacity

Chris Spivey is the editorial director of 

Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.

Serialization on a Global Scale: Deep Dive into the US DSCSA and EU FMD – Regulatory | Part 4

Sterling Pharma Solutions has announced a £10 million (US$13.5 million) investment into process development and manufacturing capacity at its site in Dudley, UK.

Sterling Pharma Solutions Invests in Process Development and Manufacturing in Dudley, UK

Serialization on a Global Scale: Deep Dive into the US DSCSA and EU FMD – Software and Data Management | Part 3

Under the expanded agreement with Agios, Centogene will provide global clinical trial support for thalassemia and sickle cell diseases.

Outsourcing

Developing the Best Formulation Partnership

Pharma Services Sector Poised for Continued Growth